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ABSTRACT 
Impact of charged silica nanoparticles on the biophysical properties of lung surfactant 
Abdullah Khan 
As oxygen is inhaled it has to first cross a very thin layered membrane, lung surfactant, before it 
can enter the bloodstream. This lung surfactant membrane is composed of saturated and 
unsaturated phospholipids and membrane proteins which serve to reduce the surface tension at 
the air-liquid interface of the alveoli preventing alveolar collapse. To maintain this function 
through repetitive compression-expansion cycles, the film employs a mechanism of reversible 
reservoir formation and exhibits a high degree of fluidity. The inhalation of nanoparticulate may 
interfere with the functional properties of pulmonary surfactant including lowering the film 
collapse, altering viscoelastic properties and modifying lipid reservoir formation. This study 
aims to determine the degree to which nanoparticles interfere with the phase structure, 
compressibility, and viscoelastic properties when they deposit on the lipid membrane. The lung 
surfactant films are modelled using monolayers comprising either lipid-only mixtures or a 
natural membrane extract, namely Infasurf (a clinical formulation containing both extracted 
lipids and proteins). Surface pressure-area isotherms, Brewster angle microscopy, rheological 
measurements and grazing incidence x-ray diffraction data of films in the absence and presence 
of cationic and anionic silica nanoparticles are presented and discussed. The charge was found to 
play an important role with cationic nanoparticles having a greater impact on structural 
properties while anionic nanoparticles affect the viscoelastic properties of the films. 
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Chapter 1. Introduction and literature review 
During the industrial revolution a significant advancement in technology was observed and with 
time technology has had an exponential growth. However, the growth in technology did come at 
a price; a steady rise in the use of coal, oil and gas was also seen. The use of such fossil fuels 
have caused an increase in the amount of airborne pollutants. The negative impacts of these 
pollutants are not solely observed on the environment but on humans and other living creatures 
as well. Acid rain, ozone layer depletion and global climate change are a few of the 
environmental effects of such pollution. Examples of health impacts of airborne pollution 
include irritation of eyes and throat, coughing and breathing difficulties and more increased 
chances of developing/worsening lung and heart problems. The focus of the thesis is on the 
impact of pollution on respiratory processes. A short review of some of the common respiratory 
irritants (ozone, tobacco smoke and particulate matter) and their impact upon inhalation on the 
respiratory system will be presented.  
1.1. Ozone 
Ozone, a powerful oxidizing agent, is mainly found in stratosphere but its presence in the 
troposphere is a result of reactions taking place with other atmospheric pollutants which lead to 
the formation of tropospheric ozone. Since the beginning of the industrial era ozone levels have 
been on the rise causing an increase from 10 ppb (in 19th century) to 45 ppb (until mid-20th 
century). This rise can be attributed to the increased use of fossil fuel and other sources of NO2 
emissions1. The increase in ozone concentrations does not only affect the climate but also 
negatively impacts human health, more specifically the respiratory system. Basha et al. showed 
inflammation in the airways of asthmatic males when exposed to 200 ppb ozone concentration, 
this inflammation was not observed in non-asthmatic males undergoing the same exposure time 
and condition, although the exposure did not cause a decrease in lung function capabilities2. On 
the other hand other studies have shown that ozone exposure does lead to a decrease in lung 
function, however, these studies were not conducted by direct ozone exposure in controlled 
environment but rather dependent on environmental exposure. More recent in vitro research with 
model lung surfactant membranes have shown that exposure to low levels of ozone cause 
dendritic cell retention in lung tissue, partial unfolding of surface active protein SP-B and 
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resulting in loss of function and causes rearrangement of lipids at the air-water interface3,4,5. All 
of these effects impair proper lung surfactant functioning. 
1.2. Environmental tobacco smoke 
Environmental tobacco smoke (ETS) is another source of airborne pollutant with negative 
impacts on the respiratory system. There are over 4000 compounds in tobacco of which 60 
compounds are known carcinogens such as benzene, nickel, aromatic hydrocarbons, nitrogen 
dioxide, sulphur dioxide, etc.  ETS also contains particulate matter, including nanoparticles 
ranging between 10 nm to 700 nm with the majority being around 150 nm, a size range of 
particulate that can travel deep into the lung6,7. Larsson et al. have shown that exposure to ETS, a 
major source of lower airway irritant, during childhood increases the chances of being diagnosed 
with asthma later on in life, even in cases where the patient is a non-smoker8. Other studies 
reveal that daily exposure to ETS, residential or in the workplace environment, has been linked 
with increased chances of lung cancer in adults (smokers and non-smokers)9. More specifically, 
exposure to ETS causes lung surfactant to rigidify, alters the monolayers ability to re-spread, and 
removal of unsaturated lipids from the air-water interface. Such changes are prone to cause 
inflammation and impairment of the lung surfactant10,11. 
1.3. Environmental pollutants (fine particulate matter) 
Nanoparticle research for use in various fields may be relatively new, however, nanoparticles 
have always been present. Recent technological advances have enabled their visualization and 
characterization.  Nanoparticles are generated on a daily basis from natural and man-made 
sources; studies show that 90% of the suspended particulate matter in the atmosphere (aerosol) 
come from natural sources whereas the remaining 10% come from man-made sources12.  
Dust storms occurring in the Salton Sea, Sahara Desert and the Namibian desert lands, amongst 
seven other major regions, have been shown to be the major source, almost 50%, of natural 
nanoparticles that are present in the atmosphere. Not only do these particles have varying size 
range (nanometer to micrometer), but they also have very long migration times, therefore, even 
though the storm may be taking place in the Indus Valley, the nanoparticles can travel to regions 
that are much further away12-14.  
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Forest fires also result in an increase in nanoparticle concentration in the air which can then 
travel and affect people that are located far away from the fire15. Lastly, although their 
occurrence is not very frequent, volcanic eruptions release a significant amount of gas, ash and 
particulate matter in the nanometer to micron range into the atmosphere which affects the 
environment around the volcanic region12.  
Nanoparticles generated from these natural sources can cause minor health impacts such 
irritation of the nose, throat, eye and skin and worsen respiratory conditions for patients that are 
diagnosed with asthma and emphysema but it can also lead to more serious diseases such 
podoconiosis, Kaposi’s sarcoma, scarring of lung tissue and can even lead to death in some 
cases12,16-18.  
In addition to naturally generated nanoparticles, anthropogenic nanoparticles are also being 
generated on a daily basis due to the use of cars, trains and other sources of transportation that 
use fossil fuel and it is the main source of man-made nanoparticles in the atmosphere19. The 
nanoparticles generated by such engines vary between 20-130 nm20. Nanoparticles are also 
released into the atmosphere in construction and demolition sites. When driving by such sites, 
thick clouds can be observed that are covering the area and the workers are asked to wear proper 
gear to protect themselves. Studies done have shown that toxic particles varying between 
nanometer to micrometer range of lead, glass, asbestos fibers, tar and others can be found at such 
sites and it can also travel with the air to affect the surrounding areas21. 
It is not only the outdoor air that gets polluted on a daily basis, the air indoors can also be 
polluted with nanoparticles. For example, in some regions cooking is done by burning wood in a 
room that often does not have proper ventilation. In regions where electricity is not very common 
candles are used for light. Even vacuum cleaners release nanoparticles in the air. Other sources 
of nanoparticles that can be found inside the house are dead skin cells, particles from our clothes 
and for those who smoke indoors there is a plethora of carcinogenic nanoparticles present in such 
households22-24. These man-made nanoparticles also have negative health impacts: even though 
nanoparticle from dead skin cells, vacuum cleaners and clothes are not deadly they can irritate 
the lower airway tract and cause an asthma attack for those diagnosed with the disease. 
Nanoparticles from burning wood, exhaust fumes, construction and demolition sites, candles and 
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cigarette smoke, however, have more serious consequences. They can lead to increased chances 
of developing nasal, lung and pancreatic cancer, cardiovascular diseases, genetic mutations, 
lower respiratory tract illnesses such as pneumonia and bronchitis, asthma and death in children 
under the age of 5 due to smoke inhalation25-29. 
1.4. Engineered nanoparticles 
The advancement in technology has not only allowed the creation of devices that are more 
efficient than their older counterparts but are significantly smaller in size as well. Although 
nanotechnology has its advantages, it has also introduced a new problem that may be affecting 
people who are involved in the production line.  The use of nanoparticles has become widespread 
due to the number of applications that are now trying to incorporate these nanoparticles in their 
products. Some examples of their uses are as follows: they are used for cancer therapy and drug 
delivery in the biomedical and health industry, used for water resistant coatings and other types 
of food packaging in the food and agriculture industry, used for making ferro fluids, quantum 
computers and high density data storage devices in the electronics industry and for making anti-
stain, medical, heat retaining textiles in the textile industry amongst numerous other uses. These 
nanoparticles are being incorporated into a wide variety of products for personal use but there is 
still limited understanding of the fate and impact of such nanoparticles on cells and biological 
systems. 
The large number of applications dictates the necessity for a large variety of nanoparticles. The 
particle core can be changed to serve different purposes. One of the most common nanoparticle 
cores is gold which is proposed for many applications, such as a sensor to detect for arsenic in 
water samples30. Silica nanoparticles have been used for cancer therapy, in which they were used 
as drug carriers that release drugs in a controlled fashion31, these particles have also been used 
for making more durable and anti-aging computer cables32. Two other very common 
nanoparticles that are used in the food, medical and cosmetics industry are zinc oxide and 
titanium dioxide nanoparticles; these particles are present in toothpaste, cosmetics, sunscreen 
lotions, paint, vitamin supplements, outer shell for medicines and in food as food coloring and 
food additives for various purposes33,34. There are many other nanoparticles that are used that 
have different particle core.  
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Another variable that can be manipulated is the particle coating, which is frequently used to give 
them specific functionality. For example, when nanoparticles are used as drug carriers and the 
coating confers biocompatibility, specificity for certain targets and/or protection from the 
environment and prevention of early drug release. 
 Nanoparticles also come in very different shapes and sizes, moreover, they can either be solid or 
hollow on the inside based on their use. Lastly, nanoparticles can have different charges on their 
surface, they can be cationic, anionic or neutral. This gives an insight in the vast number of 
different nanoparticles that are present and the variability of their properties. Nanoparticles used 
for paint, food, cosmetics, toothpaste and medicine are synthesized in bulk quantities and not 
only the workers present in manufacturing facilities but the general public that use such products 
are also exposed to these nanoparticles.  
Although these nanoparticles have been approved by the FDA as GRAS (Generally Recognized 
As Safe) studies have shown that these nanoparticles are not as harmless as initially predicted33. 
The extent of health effects are not known for all of the different types of nanoparticles that are 
present but numerous studies have been done to show the negative health impacts that some of 
these nanoparticles are causing.  
Beryllium nanoparticles which are used for making electronic parts and plastic molds have been 
known to cause allergic reactions, pneumonia, heart enlargement and higher chances of lung 
cancer35,36. Cadmium nanoparticles which are used for making batteries, plastics and metal 
coatings have been shown to cause and linked with nausea, emphysema, liver damage and cancer 
of the lungs, stomach and pancreas37,38. Aluminum nanoparticles which are present in antacids, 
antiperspirants, deodorants, food and other commercial products have been linked with bone 
disease, breast cancer and dementia, although debate is still ongoing whether or not Alzheimer’s 
disease is directly caused by excess exposure to aluminum nanoparticles39-42. Miners and welders 
have an increased exposure to manganese nanoparticles, which have been showed to cause 
neurological diseases, most commonly Parkinson’s disease43,44. Silica nanoparticles which are 
present in numerous consumer products such as paint, rubber and plastics have been shown to 
cause scleroderma, rheumatoid arthritis and lung cancer, although the association of silica 
nanoparticle exposure and lung cancer is still heavily debated45,46. Although not all of these 
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diseases are caused by nanoparticles, studies have shown that nanoparticle exposure seems to 
aggravate the conditions of patients that have been diagnosed with some of these diseases. For 
this research, the focus will be the effect of nanoparticle inhalation as a first route of entry which 
affects the lungs. 
1.5. Lung surfactant composition and function 
In humans, respiration takes place in the lungs. As we inhale, oxygen is brought inside the lungs 
and as we exhale, carbon dioxide is expelled out. The exchange of oxygen and carbon dioxide 
occurs inside the alveoli found inside the lungs. When oxygen is brought inside the body, it has 
to first cross a very thin layered membrane film called the lung surfactant before it can enter the 
bloodstream. Lung surfactant (LS) is a lipid protein monolayer film that coats the inner surface 
of the alveolar sacs and its role is to reduce the surface tension of the alveolar sacs to prevent 
alveolar collapse during the breathing cycle47,48. LS is composed of 80-90% phospholipids (of 
which 70-80% consists of saturated lipids and 20-30% unsaturated lipids), 5-10% surfactant 
associated proteins (which consists of SP-A, SP-B, SP-C and SP-D where SP-B and SP-C are 
surface active proteins and SP-A and SP-D are non-surface active proteins) and 3-10% neutral 
lipids (which mainly consists of cholesterol)49-55. Of the 70-80% saturated PC lipids that are 
present in lung surfactant, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) is the major PC 
lipid and of the 20-30% unsaturated PG lipid, 1-palmitoyl-2-oleoyl-phosphatidylglycerol 
(POPG) is the major PG lipid56. Each of these components play a specific role for proper lung 
surfactant function. Figure 1 shows a schematic of the inner surface of the alveolar sac depicting 
the breathing process. During inhalation LS is at its most expanded state (Step 1), the lipids and 
proteins are present but they are not in a highly compressed state.  As exhalation starts, the film 
is compressed which brings the lipids and proteins closer together and there is a phase separation 
that occurs between the saturated and unsaturated lipids (Step 2). With further compression the 
unsaturated lipids that are not stable at high surface pressures (low surface tensions) are expelled 
from the air-water interface (Step 3). The expelled lipids are held in lipid reservoirs anchored by 
the SP-B and SP-C proteins, this process is termed the “squeeze out” (Step 4). The formation of 
these reservoirs allows for easy reincorporation of the collapsed material back into the 
monolayer during inhalation, prevents lipid loss during breathing cycle and allows the monolayer 
film to reach much higher surface pressures without collapsing. 
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Figure 1. Schematic depicting lung surfactant activity from inhalation to exhalation57. 
Adapted from Veldhuizen et al., Biochimica et Biophysica Acta, 2000.  
1.5.1. Roles of saturated and unsaturated phospholipids 
Both saturated and unsaturated lipids play an important role for proper LS functioning. Saturated 
lipids allow LS to reach very low surface tensions during exhalation whereas unsaturated lipids 
allow LS to rapidly compress and expand during the breathing process50. Figure 2 is a schematic 
isotherm depicting the different phases a phospholipid can undergo during compression and will 
be used to better explain lung surfactant functioning. At higher molecular area the lipids are in 
the gaseous phase, in this phase the lipid tails have plenty of space and are not restricted in 
conformation. During the gaseous phase, surface pressure stays constant at 0 mN/m with 
decreasing molecular area. As the monolayer is further compressed (and the molecular area 
decreased) the surface pressure starts to increase. The molecular area at which the pressure 
begins to increase is called the critical area. This phase transition from the gaseous phase can 
result in the formation of a liquid-expanded (LE) or condensed (C) phase. In the LE phase the 
lipid tails are more restricted in mobility than they were in the gaseous phase but remain fluid 
with properties similar to a liquid alkane. If a subsequent LE-C transition is observed, this will be 
evidenced by a first-order phase transition plateau in which the pressure remains constant until 
all of the LE phase is converted to C phase. There are many different condensed phases, 
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including tilted and untilted phases. The phase diagrams for such films is well established. If 
there is a transition from a tilted (often called liquid-condensed (LC)) to an upright or untitled 
phase (often called solid-condensed), this transition is usually a second-order phase transition. At 
some point the film cannot be further compressed and remain monomolecular and the film 
buckles, a process known as collapse. DPPC undergoes all of the phase transitions shown in the 
schematic isotherm in Figure 2, except for the untilted phase, (chemical structure given in Figure 
3). These lipids can achieve the high surface pressures (near-zero surface tensions) required to 
prevent alveolar collapse. On the other hand, the isotherm of an unsaturated phospholipid such as 
POPG (Figure 3) or a saturated phospholipid with short lipid tails will be significantly different. 
An unsaturated lipid, such as POPG, due to the presence of a unit of unsaturation which inhibits 
the lipid tails from adopting an all-trans, close-packed orientation required to form a condensed 
phase, will only stay in the LE phase until collapse (at room temperature).  Additionally, the 
collapse will occur at a lower surface pressure compared to the collapse pressure of a saturated 
lipid. The fluid, LE phase of the unsaturated phospholipids maintains fluidity in the LS 
monolayer film and this fluidity allows the rapid compression and expansion of LS during the 
breathing cycle. 
 
Figure 2. Schematic representation of a phospholipid isotherm with diagrammatic depictions 
of the various phases that can be observed. 
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Figure 3. Chemical structure of (A) 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),      
(B) 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-1-glycerol (POPG) and (C) 1, 2-dilauroyl-sn-
glycero-3-phosphocholine (DLPC). 
1.5.2. Roles of lung surfactant proteins 
There are four surfactant proteins associated with lung surfactant: SP-A, SP-B, SP-C and SP-D.  
SP-A and SP-D are not surface active while SP-B and SP-C reside within the lung surfactant 
film. 
1.5.2.1. SP-A and SP-D 
SP-A and SP-D are glycoproteins with molecular weight of 36 kDa and 43 kDa, respectively, 
that are produced by alveolar type II cells that belong to the collectin family, where members of 
this family are known to have host defense functions58,59.  Earlier work to elucidate the roles of 
SP-A and SP-D had shown that they were involved in maintaining the surfactant lipid 
homeostasis and surface activity of LS. Two proteins, fibrinogen and albumin, cause severe 
inhibition of surface activity of LS lacking SP-A protein, however, once SP-A was added to LS, 
the inhibition caused by fibrinogen and albumin was completely reversed60. In the absence of 
SP-D protein enlargement of alveoli, accumulation of surfactant lipid and altered structural 
organization of phospholipids were observed in mice lung surfactant59. Both SP-A and SP-D 
have anti-inflammatory and pro-inflammatory roles; in naïve lungs these two proteins help 
minimise potential damage from continuous low level exposure from pathogens, allergens and 
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apoptosis. However, in the case of excessive exposure to pathogens, allergens and other foreign 
bodies these two proteins have pro-inflammatory roles to complement the innate and adaptive 
pulmonary immunity61. These two proteins, which can directly interact with the pathogen and 
stimulate immune cells, are also involved in protecting the lungs against invading bacteria and 
virus58,62,63. Although they have an important role to play in the proper functioning and 
protecting the lungs from pathogens, SP-A and SP-D are not surface active proteins and 
therefore are not taken into consideration for this project. 
1.5.2.2. SP-B and SP-C 
SP-B and SP-C are surface active proteins that are also produced by alveolar type II cells and are 
of interest for this research57. SP-B is an amphiphilic protein of 8.7 kDa, but in its functional 
form it is a homodimer weighing 17.4 kDa. At physiological conditions, it carries a net positive 
charge and therefore it can interact with the negatively charged POPG and other anionic lipids. 
Being amphiphilic, it also helps in membrane-membrane associations once monolayer squeeze-
out takes place52,56,57. SP-B is also responsible for proper re-spreading of lipids during expansion 
of the monolayer. Ding et al. have shown that in the absence or at very low concentrations of SP-
B, upon compression the monolayer will not fold into multilayer reservoirs rather the monolayer 
will crack when it collapses52. SP-C is a 4.2 kDa protein (the smallest of the lung surfactant 
proteins by weight) that is highly hydrophobic57. It resides within the monolayer and helps 
anchor the collapsed lipids during the breathing cycle by forming reservoirs below the air-water 
interface64. This protein also has palmitoyled chains, which helps in staying bound to the 
monolayer and it also helps in maintaining a liquid expanded phase throughout the breathing 
cycle65. Bringezu and Schurch have shown that SP-C is equally important for multilayer 
formation, lipid loss prevention and easy re-spreading of the lipids10,66. 
 
Figure 4. Schematic representation for SP-B and SP-C proteins57. 
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Figure 5. SP-B and SP-C during compression and expansion cycle67. 
1.6. Lung surfactant model membranes 
Lung surfactant is a monolayer consisting of a complex lipid-protein mixture that is found on the 
inner surface of the alveoli. Although it is a complex mixture it has key components that allow 
for its proper function and using these key components simple model membranes can be made 
in-vitro to better understand LS functions. Langmuir monolayers are a very good mimic of LS 
films in-vitro since they are spread at the air-water interface and can be compressed-expanded as 
a LS film (i.e. using similar frequencies) inducing the required lipid phase separation. Using 
monolayers that have similar composition as LS enables the study of the structure and function 
of LS and in particular the roles of each LS component, testing of new drugs for neonatal 
respiratory distress syndrome (NRDS) and other possible respiratory diseases, and evaluation of 
the impact of airborne pollutants, such as tobacco smoke, ozone, fine particulate matter and 
nanoparticles, on proper LS function27,33,48,56,58. 
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1.7. Model membrane systems 
Many monolayer compositions have been used in literature to represent lung surfactant, from 
single component DPPC to more complex natural extracts comprising a lipid-protein mixture.  
Some of the most commonly used monolayer models are described below. 
1.7.1. Lipid-only films 
Of the key components identified from LS, phospholipids are one of the main components, 
consisting of 80-90% of LS, therefore they are used to make LS membrane mimics for in vitro 
experiments50. Studies have been done using single component systems, specifically DPPC or 
POPG, since they are the representative lipids for saturated and unsaturated phospholipids 
present in the LS. Studies have also been done using mixtures of lipids of DPPC, DPPE, DOPC, 
POPG, POPC, and other lipids to determine the effect of lipid chain length and headgroup charge 
on viscoelastic properties of the model lung surfactant films. Results show that monolayers 
formed with unsaturated lipids have lower elasticity, presence of unsaturation increases lipid 
disorder and the more hydrated the lipid headgroup is the deeper it will penetrate into the water 
subphase and as a result cause an increase in viscosity52,68-70. A ratio of 70:30 DPPC:POPG 
phospholipid model membrane is frequently used to represent lung surfactant71-73. 
1.7.2. Natural extracts of lung surfactant (lipid-protein mixtures) 
Babies born before the 30 week term most often are associated with NRDS, which is a common 
problem in neonatal babies where the lungs are deficient in pulmonary surfactants, therefore, the 
lungs are not working properly and there is not enough gas exchange taking place74. The 
treatment for NRDS is lung surfactant replacement therapy (LSRT), where the babies are given 
supplemental lung surfactant to compensate for the deficiency. LSRT mainly consists of the 
necessary pulmonary surfactants which help with proper lung functions, where the non-surface 
active proteins (SP-A and SP-D) have been removed. There are numerous LSRTs available for 
use, such as Exosurf, Curosurf, Infasurf and Survanta to name a few, they are mainly derived 
from porcine or bovine lung lavages but they differ in lipid and protein concentrations73. 
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Figure 6. Lipid-protein compositions of the various lung surfactants that are used as model 
membranes73. This table is adapted from Zhang, H et al., Biochimica et Biophysica Acta, 
2011, 1808, 1832-1842. 
Of the many different LSRTs available Survanta, Curosurf and Infasurf are most commonly used 
to treat NRDS75. Curosurf is derived from porcine lung lavage and has phospholipids and the 
surface active proteins, however, the non-surface active proteins and cholesterol have been 
removed. Both Survanta and Infasurf are derived from bovine lung lavage, therefore, they should 
have very similar phospholipid composition and do not have surface-inactive proteins. They both 
have the surface active proteins (SP-B and SP-C) but in differing amount; Survanta is SP-C rich 
and has very small amount of SP-B protein whereas Infasurf is SP-B rich and has moderate 
amount of SP-C protein compared to Survanta and Curosurf, but the major difference between 
Survanta and Infasurf is that Survanta has added palmitic acid and DPPC73.  
Clinical studies done to compare the efficacy between Survanta and Infasurf have shown that 
whether for treatment or prevention of NRDS in neonatal infants the number of doses are the 
same between the two LSRTs. However, the interval time between doses are longer for Infasurf 
than it is for Survanta, in other words, Infasurf provides a longer lasting effect than Survanta76. 
Comparative studies between Survanta and Infasurf done by Notter et al. have shown that both 
Survanta and Infasurf had less total protein than natural LS, as proteins are lost during lung 
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lavage and extraction process, however, Survanta had a significantly lower protein content than 
Infasurf, more specifically Survanta was lacking SP-B protein. Primarily due to the lack of SP-B 
protein and other differences in lipid composition Survanta was unable to reach very high surface 
pressures relative to Infasurf54. In order to see whether the inability of Survanta to reach high 
surface pressures similar to Infasurf was due to the lack of SP-B protein, Notter et al. did 
comparison studies. The comparison was between Infasurf, Survanta and Survanta with 
additional SP-B protein. With the addition of SP-B protein Survanta showed similar values to 
that of Infasurf54. The importance of SP-B protein was also demonstrated by Ding et al. through 
the use of similar experiments of adding excess SP-B protein to a monolayer52. These LSRTs 
very closely resemble human LS and therefore using these as model membranes for research 
purposes can give very accurate results as to how human LS would be impacted in the presence 
of nanoparticles77. 
1.8. Lung surfactant model membranes and nanoparticles 
A significant body of research has been undertaken to determine the impact of nanoparticles on 
the respiratory system. Both computational and experimental methods have been employed to 
study different model lung surfactant membranes with a variety of nanoparticle types (e.g. 
variations in size, shape, hydrophilicity and surface charge).  An important parameter is whether 
the particles are co-spread (hydrophobic particles) with the lipid monolayer or added to the 
aqueous subphase (hydrophilic particles) beneath the lipid monolayer. 
Lin et al. used computational methods to understand the effect of changing shape, size and 
hydrophilicity of the particles during the compression-expansion process. The simulated 
monolayer consisted of DPPC only, the nanoparticle sizes examined were 3 nm and 5 nm and the 
shapes tested were rod, barrel and disk. The nanoparticles were introduced from the air phase 
(placed on top of the monolayer) and both hydrophilic and hydrophobic nanoparticles were 
tested, the monolayer was then “spread” on top of the subphase. The hydrophilic nanoparticles 
were found to penetrate deeper into the monolayer to get closer to the hydrophilic headgroup 
whereas hydrophobic nanoparticles tend stay near the hydrophobic lipid chains. The larger the 
nanoparticle, the more lipids it pulls down into the subphase along with it during the 
compression and the more it affects the monolayer. In terms of shape, a rod shaped nanoparticle 
can penetrate the monolayer most easily compared to disc or barrel shaped nanoparticles 
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(rod>disc>barrel). The main reason behind this ranking is the contact area of the nanoparticle; 
rod shaped NPs have the smallest contact area, whereas barrel shaped NPs have the largest 
contact area and the disc shaped NPs have a contact area that is in between the two. The larger 
the contact area of the NP the more contact it will make with the monolayer and the harder it will 
be for it to penetrate below the monolayer78.  
There is a plethora of experimental work testing the impact of nanoparticles on lung surfactant 
model membranes. These studies focus on the hydrophobicity of the nanoparticles, surface 
charge and particle size. Moreover, nanoparticle concentration and method of introducing the 
nanoparticles into the monolayer is also tested. Focus is also placed on the type of monolayer 
being studied; there are simple monolayers which consist of one lipid (DPPC), a mixture of 
lipids (PG:PC lipids), lipid-protein mixtures and lipid-protein-cholesterol mixtures as well. Work 
done by Harischandra et al. has shown that hydrophobic polyorganosiloxane nanoparticles are 
attracted to the air-water interface and can form a nanoparticle monolayer79. Isotherms and 
compression-expansion cycles of DPPC:DPPG and DPPC monolayers in the presence of these 
hydrophobic polyorganosiloxane NPs (co-spread with the monolayer film) indicate that these 
NPs interact strongly with the lipid monolayer, disturb the domain structures formation by 
causing a fluidization of the monolayer and tend to be located around domain borders. Rheology 
studies carried out using a Langmuir trough with an oscillating barrier in the presence of 
hydrophobic NPs in DPPC monolayer have shown that NPs cause an increase in disorder of 
monolayer and hinders elasticity80. The rheological parameter viscosity is a measure of the 
fluidity or the ability of the film to spread and is dominated by lipid headgroup interactions with 
the subphase and neighboring headgroups whereas elasticity reflects the recovery of the film 
after the removal of stress which is dominated by lipid chain interactions70. 
Studies have also been done to observe the effects of 1 wt% of hydrophilic silica nanoparticles 
on model lung surfactant monolayers, where monolayers consisted of mixtures of DPPC, DOPC 
and cholesterol of differing amounts. Unlike the hydrophobic nanoparticles, that can form a 
nanoparticle monolayer at the air-water interface, the hydrophilic silica nanoparticles remain 
dispersed in the subphase and do not cause an increase in surface pressure upon compression of 
the barriers81,82. However in the presence of a monolayer these nanoparticles are attracted to the 
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surface and interact with the lipids present at the air-water interface. The interaction causes the 
isotherm to shift to higher molecular areas and the phase transition plateau to disappear83. 
The rheological properties of model membranes are indicative of their ability to rapidly 
compress and expand through the breathing cycle and have been used to evaluate the biological 
impact of inhaled particulate. In the presence of hydrophobic fumed silica nanoparticles for 
model lung surfactant membranes consisting of a single type of lipid Guzman et al. observed that 
the effect on rheology was that the oscillations were increasing in amplitude and thereby causing 
harmonic distortions, which indicates that there is nanoparticle incorporation with the monolayer 
film present at the air-water interface. Moreover, the presence of these hydrophobic fumed silica 
NPs caused an increase in disorder and hindered domain formation. The incorporation of these 
NPs to the lipid causes a strong steric hindrance and thereby prevents the normal function of the 
lipid monolayer80. 
Within the literature reports of nanoparticle impacts on lung surfactant films, the composition of 
the model lung surfactant membrane, the size, shape and type of nanoparticles and the 
methodology vary significantly. Despite this, a general consensus is emerging that nanoparticles 
causes distortions in domain formation, increases disorder in monolayer structure, causes 
fluidization of the monolayer and as a result proper functioning of the monolayer is affected. 
1.9. Research objectives 
Our research focuses on correlating the effect of nanoparticles on the structure, morphology and 
rheological parameters (viscosity and elasticity) of lung surfactant films.  To understand the role 
of the model film and particle characteristics, both the lipid only and lipid-protein monolayers 
were studied as a function of membrane composition, particle concentration and particle charge. 
For this work three types of silica nanoparticles were chosen as they have widespread 
applications in construction materials and biomedical applications. Silica nanoparticles are 
surfactant free, low polydispersity, commercially available and have variable size, surface charge 
and particle coating. The nanoparticles used for this research were provided by AkzoNobel and 
include cationic, anionic and neutral silica nanoparticles that are of the same order of magnitude 
in size. 
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The four systems that were chosen for this work are DPPC, 70:30 DPPC:POPG mixture, 70:30 
DPPC:DLPC mixture and Infasurf. The first three are lipid-only systems and the latter, Infasurf, 
is a natural extract comprising of lipids and proteins. DPPC is a saturated lipid found in high 
concentration in lung surfactant.  It is frequently employed to represent the condensed phase of 
lung surfactant.  Use of this single component system enables an understanding of one portion of 
the film but does not mimic the overall phase behaviour very well as it lacks a fluid phase at 
physiologically relevant surface pressures. A 70:30 DPPC:POPG mixture is used as a simple 
lung surfactant model without the proteins, chosen because both DPPC and POPG are found in 
high concentration in natural lung surfactant and a 70:30 ratio is a representative ratio of 
saturated and unsaturated lipids in lung surfactant57,69,83. This system forms a DDP-rich 
condensed phase and a POPG-rich liquid expanded phase. A 70:30 DPPC:DLPC mixture was 
chosen to keep the same ratio of condensed and liquid expanded phases but without the negative 
charge of POPG.  DLPC, with the same zwitterionic headgroup as DPPC, has shorter lipid chains 
(C12) and so it stays in the liquid expanded phase until collapse. This system is used to evaluate 
the role of the charge of the fluid phase. Finally, Infasurf is a purified, natural lung surfactant 
extract and is used for lung surfactant replacement therapy. It is extracted from bovine and has 
the surface active SP-B and SP-C protein but not the SP-A and SP-D protein which are non-
surface active. 
The use of these systems will allow for a comparison between the effect of nanoparticles on lipid 
only versus lipid-protein monolayers and the effect of nanoparticles on differing amounts of 
protein in the system. Rheological changes were monitored using a profile analysis tensiometer 
(PAT) whereas surface activity was monitored using both a PAT and a Langmuir film balance. 
The Langmuir film balance was also coupled with Brewster angle microscopy to study the 
morphological changes taking place.  Synchrotron Grazing Incidence X-ray Diffraction (GIXD) 
measurements are used to evaluate structural changes in the monolayers. 
Of particular note, most studies focus on relatively high concentrations on nanoparticles.  For 
hydrophilic nanoparticles dispersed in the subphase, these concentrations are often close to 1 
wt%. In this work, the effect of 0.001% cationic, anionic and neutral silica nanoparticles on the 
different model lung surfactant membranes is studied; this concentration is the lowest 
concentration at which an impact on any of the isotherms was observed and is significantly lower 
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than previously reported in the literature. Additionally, the effects are also studied as a function 
of concentration from this low value of 0.001 wt% up to 0.5 wt%.  In all cases we seek to 
correlate structure and morphology changes to rheological parameters. 
  
  19 
Chapter 2. Materials and methods 
2.1. Materials 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2oleoyl-sn-glycero-3-
phosphoglycerol (POPG) and 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) were obtained 
in the powder form (Avanti Polar Lipids, Purity > 99%) and dissolved in chloroform (HPLC 
grade, Fisher Scientific) to make stock solutions. Ultrapure water (resistivity 18.2 M-Ω cm-1) 
was obtained from an Easypure II LF purification system. Survanta and Infasurf was donated by 
Abbott Laboratories and Ony Inc, respectively. Levasil 200S (cationic), Bindzil 30/360 (anionic) 
and Bindzil 2034 DI (neutral) nanoparticles used for this research were provided by AkzoNobel 
and were supplied as aqueous suspensions. 
2.2. Monolayer spreading solutions 
The lipid mixtures were prepared by mixing aliquots of the stock chloroform solutions of DPPC, 
DLPC and/or POPG to obtain a molar ratio of 70:30. Infasurf were first lyophilized and then 
mixed with chloroform to obtain the desired concentration. 
2.3. Subphase preparation and characterization 
Nanoparticle suspensions were diluted with ultrapure water to obtain the desired nanoparticle 
concentration (given as weight %). The nanoparticle suspensions showed no significant surface 
activity (data not shown). The nanoparticle size and particle charge had been previously 
characterized using DLS and zeta potential using dispersions of the same concentrations as used 
in the experiments. Levasil (cationic) nanoparticles are 24 ± 7 nm in diameter and +42.8 ± 0.9 
mV, Bindzil (anionic) nanoparticles are 17 ± 5 nm in diameter and -11.7 ± 4.1 mV and Bindzil 
DI (neutral) nanoparticles are 30 ± 10 nm in diameter and -35.0 ± 3.2 mV. When the neutral 
nanoparticles were first obtained from AkzoNobel they were neutral in charge but acquired an 
anionic charge over time. For this reason, the results from the neutral nanoparticles are only 
included in Appendix A rather than the main text.  It should be noted that in all cases, the neutral 
nanoparticles behaviour was similar to that of the anionic nanoparticles. 
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2.4. Profile analysis tensiometer 
Isotherms and rheology measurements were obtained using a pendant drop, profile analysis 
tensiometer (PAT). The PAT analyses the profile of the drop shape using the Young-Laplace 
equation to relate the curvature of the drop to an interfacial pressure value83-86. For obtaining 
isotherms using the PAT, model lung surfactant monolayers were spread on the surface of a 13 
μL (corresponding surface area is 32 mm2) drop of the subphase at the tip of a capillary. 
Spreading volumes ranged from 0.3 to 0.7 μL. Once the monolayer is spread on the drop surface, 
the surface area of the drop is increased to 40 mm2 (26 μL) and was then allowed to equilibrate 
for 30 minutes. The waiting time also allowed the evaporation of chloroform from the surface of 
the subphase. Once the equilibration time was over, the drop area was adjusted to 40 mm2 before 
compression was started. The monolayer is compressed due to the decrease in drop volume 
which is controlled by the micro-syringe pump at a pre-determined speed. The monolayer was 
compressed at a speed of 8 Å2/molecule/minute until collapse to generate the isotherm. All 
isotherms were performed in at least duplicate and one representative isotherm is shown. The 
spreading error is approximately 7 ± 3 Å/molecule. 
The monolayers for rheology measurements were prepared using the same method.  For these 
measurement, a step through rheology (STR) program was used to obtain rheology 
measurements at different pressures using the same monolayer. Once the monolayer has been 
spread on the surface of the drop of water and allowed to equilibrate for the specified amount of 
time, the STR program was then started. The initial drop area is at 40 which is then compressed 
to 30 mm2 at a compression speed of 8 Å2/molecule/minute, the drop is then allowed to 
equilibrate for 300 seconds (5 mins) followed 600 seconds (10 mins) of sinusoidal oscillation of 
the drop area. Once the oscillations were complete, the drop was allowed to equilibrate for 300 
seconds (5 minutes), followed by a small compression to increase the surface pressure by 2 – 3 
mN/m, after which the drop was allowed to equilibrate for 300 seconds before the drop area 
underwent sinusoidal oscillations once again. This procedure was repeated to obtain rheology 
values for a pressure range of 10 – 55 mN/m for the same monolayer.  
As the drop area is sinusoidally oscillated, the variation in surface pressure is recorded. The data 
obtained is then fitted using a Fourier transform after which the oscillations can be analyzed to 
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obtain viscosity and elasticity values at the specified surface pressure: the fitting procedure has 
been previously described 85.  
As part of the data analysis procedure, each data point is evaluated and either retained or 
discarded based on the Total Harmonic Distortion (THD). The drop area was oscillated 
sinusoidally, therefore the surface pressure response is also sinusoidal in shape. The THD is a 
measure of how closely the oscillation data follows a reference sinusoidal shape; a lower THD 
implies a better fit.  If the THD of the selected data point was lower than 15% then it was 
retained otherwise it was discarded. Thus, not all systems have an equivalent number of rheology 
data points. 
Vrânceanu, Krägel and Wüstneck determined that the oscillation frequency of the drop should be 
such that it does not force the drop shape to deviate from its normal shape otherwise it will not fit 
to the Young-Laplace equation83-85. Moreover, the oscillation amplitude of the drop should 
always be kept below 10% of the actual drop area in order to prevent the drop shape 
deformation87. For our experiments the parameters chosen for frequency was 0.025 s-1 and the 
amplitude during oscillations was kept at 2.5% of the actual drop size in order to prevent drop 
shape deformation, early monolayer collapse and the drop falling off from the capillary. All 
rheology measurements are performed in duplicate and the data are presented as an overlay of 
two independent measurements, i.e. measurements on two independently prepared films. The 
“detachment pressure” for the PAT instrument refers to the pressure at which the drop detaches 
from the capillary. 
2.5. Langmuir film balance 
Traditionally surface pressure-area isotherms are generated using a Langmuir film balance. 
Moreover, it can be combined with optical imaging techniques as described below. For these 
measurements the subphase solution and monolayer solutions were prepared in the same manner 
as for pendant drop experiments, however, the spreading solution is 10-fold more concentrated. 
The monolayer film is spread at the air-water interface in the region between two moveable 
barriers and allowed to equilibrate as described in the previous section. To generate the isotherm, 
the two barriers are closed at 5 Å2/molecule/minute which compresses the monolayer film.  
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Brewster angle microscopy (BAM) is used to image film morphology. P-polarized light is 
reflected at the water surface at the Brewster angle, the angle for total internal reflection.  This 
angle is a function of the refractive indices of the two phases, in this case air and water. Upon 
spreading of an organic film at the air/water interface, the optical properties of the interface are 
altered and light is reflected. The different monolayer phases have different optical properties 
and generate different light intensities at the detector, thus enabling the observation of phase 
separation within the monolayer films. 
 
Figure 7. Schematic representation of Brewster angle microscopy. 
These measurements were made using a custom Langmuir film balance (NIMA Technology) 
with a high aspect ratio (35 cm by 5 cm) that is coupled with an I-Elli2000 imaging ellipsometer 
(Nanofilm Technologies) comprising a 50 mW Nd:YAG laser (λ = 532 nm) and a 20x 
magnification lens set at an incident angle of 53.15°(the Brewster angle for an air/water 
interface). 
2.6. Grazing incidence X-ray diffraction 
In order to get a better understanding of how the nanoparticles are interacting with the model 
lung surfactant monolayer films, grazing incident X-ray diffraction (GIXD) experiments were 
performed at beamline 15-ID-C ChemMatCARS at the Advanced Photon Source (APS) in 
Argonne National Laboratory with the following parameters: x-ray beam wavelength of 1.239 Å, 
incident angle of 0.0906°, horizontal size of 20 μm, vertical size of 120 μm using gave a beam 
footprint of 20μm by 7.6 cm. The detector used was 2D Swiss Light source PILATUS 100K set 
to single-photon counting mode. Two sets of slits, one placed in front of the detector and the 
other placed 292.0 nm from the sample, where used to minimize intense low-angle scattering. 
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Experiments were done at the air-water interface of a 340 cm2 Langmuir film, where the 
monolayer was spread and then compressed at a specified speed using a mobile barrier. The 
subphase solutions and monolayer solutions were made in the similar method as described for 
the BAM experiments. The data was analyzed using OriginPro 2016.  
GIXD involves the use of x-rays from a synchrotron source at an angle of incidence below the 
critical angle for total reflection. Ordered arrays of molecules (in this case the all-trans, fully 
extended chains of the condensed phase) will give rise to diffraction peaks. All diffraction peaks 
are analyzed as a function of the in-plane (Qxy) and out-of-plane (Qz) diffraction components 
which yield information on the lattice parameters and molecular tilt angles and direction. It is 
important to note that only condensed phase lipids will give rise to diffraction peaks. The peak 
position in Qxy yields the unit cell spacings while the position in Qz yields the tilt angle of the 
lipid chains; the full width at half maximum (FWHM) in Qxy provides information on the 
crystallinity (referred to as the coherence length, lc) of the ordered phase. The FWHM in Qz 
correlates to the length (L) of the scattering rod (alkyl chain thickness).  The formulas for 
calculation of these parameters are88: 
d = (2 x π) / Δqxy      and      lc = ((2 x π) / Δqxy) x 0.9 
L = 0.9 x ((2xπ) / FWHMQz) 
 
Figure 8. Schematic of Grazing incidence diffraction and possible tilt angles89. Adapted from 
O’Flaherty et al. Langmuir, 2005, 21, 11161-11166. 
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Chapter 3. Impact of charged silica nanoparticles on model 
lung surfactant systems 
Section 3.1 and 3.2 focus on the characterization of the four model membranes and the impact of 
low concentrations of charged silica nanoparticles dispersed in the subphase.  Only the results for 
anionic and cationic silica nanoparticles are shown as the “neutral” nanoparticles had acquired a 
negative charge at the time these experiments were carried out.  For completeness, the data for 
the same systems on subphases containing neutral nanoparticles are included in Appendix A.  
Grazing Incidence X-ray Diffraction data is included for the DPPC, 70:30 DPPC:DLPC and 
70:30 DPPC:POPG systems.  Postdoctoral fellow, Shirin Behyan, guided the analysis and 
interpretation of the GIXD data that has been published as Nanoparticle-Induced Structural 
Changes in Lung Surfactant Membranes: An X-ray Scattering Study, Shirin Behyan,  Olga 
Borozenko,  Abdullah Khan,  Manon Faral,  Antonella Badia  and  Christine E. DeWolf  
Environmental Science: Nano, 2018, DOI: 10.1039/C8EN00189H. 
3.1. Characterization of the model membranes 
The surface pressure-area isotherms obtained using the pendant drop tensiometer for the four 
systems, DPPC, 70:30 DPPC:DLPC, 70:30 DPPC:POPG and Infasurf on water, are shown in 
Figure 9. All isotherms are in good agreement with the literature73,90-92. In order to obtain the 
isotherm, the lipid film is spread on a pendant drop and the drop area is reduced.  The maximum 
pressure that can be obtained with this method is limited as the drop detaches from the capillary 
at very small drop volumes. The expanded nature of these films generates isotherms that occur 
over a large range of molecular areas, thus drop detachment occurs before film collapse would 
normally be observed using a traditional Langmuir film balance.  
 For the single component (DPPC) film, the liquid-expanded to condensed (LE-C) phase 
transition, takes place around 10 mN/m and is exhibited as a horizontal plateau in the isotherm. 
Over the phase transition the relative proportions of these two phases (LE and C) change until 
the film is fully condensed in a tilted phase, as it already is well established. In the case of the 
binary lipid mixtures, the phase transition is less sharp and is shifted to a higher surface pressure, 
around 17 mN/m. The POPG lipid has one unsaturated chain and the presence of the double 
bond in one of the alkyl chains hinders it from forming a condensed phase at room temperature, 
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therefore, stays in the LE phase until collapse. Although DLPC is a disaturated lipid, the 
relatively short tails only have 12 carbons, which is not long enough for it to form condensed 
phase at room temperature and therefore the isotherm of a DLPC film will also remain in the LE 
phase until collapse. The main phase transition temperature (Tm) for both POPG and DLPC is     
-2°C93. A squeeze-out of the LE phase at higher pressures has been reported for such phase 
separated binary mixtures (often observed as a second plateau) as the LE phase has a lower 
collapse pressure.  This is then followed by an increase in pressure for the remaining condensed 
phase components which are stable to much higher surface pressures (lower surface tensions)73.  
This was not observed but such transitions can be difficult to obtain on a drop tensiometer with 
the much smaller surface areas and low drop stability at small drop areas/volumes. 
Infasurf not only has a mixture of saturated and unsaturated lipids but it also contains the 
surfactant proteins SP-B and SP-C; the phase transition is no longer visible in the isotherms 
despite phase separation occurring due to the complexity of the mixture (a mixture of chain 
lengths, degrees of saturation and headgroups for the lipids)73. Additionally, the proteins 
maintain some LE phase even with squeeze-out and reservoir formation (associated with the 
plateau at 45 mN/m)65. It should be noted that the molecular areas reported for Infasurf in the 
isotherms are arbitrary values since the exact composition is not known. For comparison to the 
well-defined lipid only systems, the amount of Infasurf spread was adjusted to yield a similar 
critical area. After the squeeze-out, the pressure begins to increase again, although it is not 
possible to compress until collapse with the pendant drop. 
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Figure 9. Surface pressure-area isotherms of the four model membranes on a water subphase at room 
temperature. Note that the molecular area for Infasurf is arbitrary as the molecular weight for this natural 
extract is not known. 
Figure 10 shows the viscosity and elasticity data for the four different systems on a water 
subphase. DPPC exhibits the highest viscosity and elasticity values compared to the other three 
systems at moderate to high pressures. Anton et al. have compared six different lipids, with 
varying head groups, lipid chain length and units of saturation in lipid chains, and have found 
that viscosity is mainly dominated by head group interactions between neighboring lipids and 
with the subphase. On the other hand, elasticity is regulated by lipid chain interactions and lipid 
phase. Saturated lipids that form condensed phases have higher elasticity than unsaturated lipids, 
where the units of unsaturation decrease the chain ordering and packing. Furthermore, units of 
unsaturation decrease lipid chain interaction which results in lower elasticity70. DPPC headgroup 
is zwitterionic compared to POPG headgroup which has an overall negative charge. There is 
charge repulsion between headgroups, which creates a larger distance between them and 
therefore lowers possible hydrogen bonding between headgroups as demonstrated by Pimthon et 
al.94. 
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For all four systems, very low viscosities are observed at low pressures when the film is in a LE 
phase, until the onset of domain formation, which is usually observed even before the surface 
pressure is registered as a plateau in the isotherm.  For DPPC, condensed phase domains begin to 
appear around 5 mN/m and these begin to coalesce above 10 mN/m73. The viscosity increases 
with increasing proportion of condensed phase domains until coalescence at which point there is 
a distinct change in slope.  This slope above 10 mN/m correlates to the viscosity values for a 
condensed phase with a slope representative of the change in chain tilt angle due to 
compression73.  
For DPPC:POPG and DPPC:DLPC, the isotherms showed a broadening of the phase transition 
over a larger range of surface pressures, a trend also evident in the viscosity and elasticity data.  
One significant difference between the two is the behaviour at higher surface pressures.  For the 
DPPC:DLPC system, the DLPC-rich LE phase is more stable and persists to higher surface 
pressures90, correlating with the low slope in viscosity and near constant elasticity values above 
20 mN/m.  Nojima and Iwata estimated the viscosity inside lipid bilayers formed by different 
phosphatidylcholines and demonstrated that despite both DPPC and DLPC being saturated lipids, 
DPPC has a significantly higher viscosity than DLPC due to the phase formed95. On the other 
hand, the POPG-rich LE phase is less stable and begins to be squeezed out at lower pressures, 
leading to values that begin to move towards those of pure DPPC70.  By 40 mN/m the POPG LE 
phase appears to be fully squeezed out of the surface96. 
Infasurf exhibits a fairly small increase in viscosity and elasticity and maintains those values 
throughout the pressure range, moreover, it has the lowest viscosity and elasticity values 
compared to the other systems.  With the large mixture of chain lengths and degrees of 
saturation, domain formation begins below 5 mN/m, domain sizes are variable with co-existing 
micron and nanometer sized domains and there is a significant proportion of LE phase at all 
pressures, all giving rise to the long continuous increase in viscosity96. 
These differences are mirrored in the elasticity measurements. There is a distinct change in slope 
with the onset of domain coalescence.  For DPPC, which exhibits full coalescence, the elasticity 
continues to increase as the film is compressed, while for the other systems, in which a LE phase 
is present, the elasticity is dominated by this phase and plateaus once all of the condensed phase 
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is formed (with the exception of DPPC:POPG which shows a second increase as the LE phase is 
squeezed out and eventually reaches values similar to DPPC upon full coalescence, whereas 
DLPC is stable to much higher surface pressures).  For Infasurf, these results are consistent with 
one of the reported roles of the surface active proteins SP-B and SP-C, namely to moderate 
viscosity and elasticity and maintain fluid phase at the interface until the film is collapsed50. 
 
Figure 10. Viscoelasticity measurements of the four model membranes on a water subphase 
at room temperature. Each data set comprises duplicate measurements made on two, 
independently prepared films. 
3.2. Impact of low concentrations of silica nanoparticles on lung 
surfactant model membranes 
The impact of low concentrations of charged silica nanoparticles on the four model membranes 
was studied via their impact on the surface pressure-area isotherms, surface rheology and 
condensed phase structure. 
3.2.1. Isotherms for model membranes spread on silica nanoparticle 
subphases 
The impact of 0.001 wt% cationic and anionic silica nanoparticles on the surface pressure-area 
isotherms of the four model membranes are shown in Figure 11. 
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Figure 11. Surface pressure-area isotherms of each of the model membrane systems (A: 
DPPC, B: DPPC:DLPC, C: DPPC:POPG, D: Infasurf) spread on the three subphases 
(water: black, 0.001 wt% cationic silica nanoparticles: red, 0.001 wt% anionic silica 
nanoparticles: blue) at room temperature. 
For three systems, DPPC, DPPC:DLPC and Infasurf, the isotherms are all very similar to each 
other in shape with only slight changes in the area per molecule in the presence of 0.001 wt% 
charged silica nanoparticles. On the other hand, the nanoparticles have a larger impact on the 
DPPC:POPG system with the negatively charged film that comprises a highly negatively charged 
POPG-rich LE phase and slightly negatively charged DPPC-rich condensed phase. Despite the 
negative charge, the cationic nanoparticles appear to have a minimal impact on the molecular 
area.  On the other hand, the anionic nanoparticles induce a shift to higher molecular areas (the 
Bindzil DI nanoparticles, induce an even larger shift to higher molecular areas when they are 
  30 
negatively charged as shown in Appendix A). The anionic nanoparticles may preferentially 
interact with the positive charge of the zwitterionic choline headgroup inducing either a change 
in the orientation of the lipid in this phase or inducing repulsion between the adsorbed anionic 
nanoparticles and the surrounding highly anionic LE phase.  
The presence of nanoparticles not only causes changes in isotherm but also affects the domain 
morphology of the lipid film. McConnell and McConlogue et al., have shown that in water 
DPPC domain morphology are bean shaped but Chakraborty et al. have shown that in the 
presence of 1 wt% anionic, hydrophobic nanodiamonds that are co-spread with the lipids, the 
shape is altered. For DPPC, the domains no longer maintain their characteristic bean-shape but 
adopt a more stretched out spiral structure. The change in domain shape observed by them 
indicates a lowering of the line tension between the LC domains and LE area92,97,98. This effect 
was also observed for a 70:30 DPPC:POPG lipid film, attributed to the preferential interaction of 
the nanodiamonds with the LC DPPC domains while avoiding the fluid POPG phase98. 
Unusually, they reported no change in the isotherms despite the incorporation of a hydrophobic 
nanoparticle and despite the additional charge-charge repulsion between the anionic 
nanoparticles and anionic LE phase. One might also expect an expansion for Infasurf which 
contains a significant proportion of anionic lipids, however, the cationic proteins (SP-B) can 
shield the anionic lipid from the impact of charged species in the subphase, thus limiting the 
isotherm changes due to the adsorption of the nanoparticles96. 
3.2.2. Rheological data for model membranes spread on silica nanoparticle 
subphases 
The rheology data for DPPC on all three subphases, i.e. the absence of nanoparticles (water 
subphase) and the presence of 0.001 wt% cationic or anionic silica nanoparticles are shown in 
Figure 12. In agreement with the isotherms, the slight differences in the plateau pressures are 
reflected in the viscosity and elasticity data. In the LE phase, the DPPC rheology is unaffected by 
the presence of the nanoparticles but the behaviour differs above the phase transition. DPPC has 
high viscosity values in the absence of nanoparticles. The presence of either cationic or anionic 
nanoparticles induce a significant decrease in viscosity. Given this behaviour is reminiscent of 
the plateau in viscosity observed with mixed lipid systems, it is tempting to attribute this 
behaviour to the presence of a LE phase, however Brewster angle microscopy imaging (data not 
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shown) confirms that the film is a homogeneous condensed phase on the micron scale. Viscosity, 
the resistance to flow, is associated with head group-head group and head-group subphase 
interactions and these are clearly disrupted in the condensed phase in the presence of particles. 
Similarly, the DPPC elasticity appears only to be affected by the presence of nanoparticles at 
surface pressures above the phase transition pressure. Unlike the viscosity, the presence of 
nanoparticles induces a distinct increase in elasticity. Again, the impact was the same 
irrespective of the nanoparticle type present. Elasticity represents the stress/strain relationship for 
the film (the force or stress required to produce a change in area or strain). Thus a high elasticity 
implies a low deformation for a given stress. It is also related to the change in surface tension 
with respect to a change in area. In the condensed phase, the presence of any particles in the 
subphase appears to generically increase the film’s resistance to deformation, which may be 
related to the size of the particle (a rough area calculation would suggest that each adsorbed 
nanoparticle would interact with hundreds of lipids). 
 
Figure 12. Viscoelasticity measurements of DPPC monolayers spread on different subphases 
at room temperature: water (black), 0.001 wt% cationic silica nanoparticles (red) and 
0.001 wt% anionic silica nanoparticles (blue). Each data set comprises duplicate 
measurements made on two, independently prepared films. 
With the phase separated, binary lipid systems (Figures 13 and 14), the impact of the 
nanoparticles on the viscosity and elasticity reflects the differences in the isotherm and the 
surface pressures at which phase transitions occur much more than the magnitude of the values 
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attained, i.e. the same viscosity/elasticity-surface pressure relationship with a shift to higher 
surface pressures. For DPPC:DLPC it was noted in section 3.1 that the increase in viscosity and 
elasticity above the phase transition were moderated in these systems due to the continuous 
presence of LE phase. The viscosity appears to show a step-change immediately after condensed 
phase domains begin to appear, whereas the elasticity shows a continuous change over the phase 
transition and levels out only after the end of the phase transition region. The only discernable 
difference in the magnitude of the viscosity in the presence of nanoparticles (Figure 13) occurs 
after the phase transition and again both nanoparticle types induce a decrease in viscosity, albeit 
much smaller as the viscosity is already lower. This time there is no apparent change in elasticity 
after the phase transition, attributed to the presence of the LE phase. The film elasticity is 
dominated by the properties of the LE phase that are already lower than the C phase, therefore 
lessening the impact of the nanoparticles. It should be noted that the anionic nanoparticles show 
a shift of the phase transition to higher surface pressures that is more prominent in the 
rheological data than the isotherms. 
 
Figure 13. Viscoelasticity measurements of 70:30 DPPC:DLPC monolayers spread on 
different subphases at room temperature: water (black), 0.001 wt% cationic silica 
nanoparticles (red) and 0.001 wt% anionic silica nanoparticles (blue). Each data set 
comprises duplicate measurements made on two, independently prepared films. 
The interaction of nanoparticles with the DPPC:POPG monolayer produces a similar trend. 
Again, there is little impact of the nanoparticles on viscosity or elasticity at low pressure, when 
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all components are in a LE phase (Figure 14). The phase transition is much more prominent in 
both the viscosity and elasticity data, perhaps due to the separation into two phases of distinct 
charge and/or headgroup.  It was anticipated that the cationic particles would be attracted to the 
POPG causing a large impact on viscosity and elasticity, which was not observed. Similarly, 
despite large changes in the isotherm position, it seems the net elasticity of the films, dominated 
by the presence of a fluid phase, is unaffected. The impact of particles appears only above 30 
mN/m, i.e. at pressures where the anionic POPG is thought to be squeezing-out of the film.  At 
these higher pressures an increase in viscosity is observed in the presence of anionic particles. As 
discussed earlier, it is likely that the anionic nanoparticles are interacting with the DPPC-rich 
condensed phase rather than the POPG-rich LE phase.  The anionic nanoparticles adsorbed on 
the condensed phase cause a repulsion between islands and matrix, increasing the viscosity for 
this system. Such a repulsion would not be observed when the LE-phase is zwitterionic 
(DPPC:DLPC) or when there is no LE phase (DPPC). 
 
Figure 14. Viscoelasticity measurements of 70:30 DPPC:POPG monolayers spread on 
different subphases at room temperature: water (black), 0.001 wt% cationic silica 
nanoparticles (red) and 0.001 wt% anionic silica nanoparticles (blue). Each data set 
comprises duplicate measurements made on two, independently prepared films. 
Finally, the anionic nanoparticles cause a similar impact on Infasurf as was observed with 
DPPC:POPG, namely an increase in viscosity above 30 mN/m and increase in elasticity over the 
course of the phase transition (Figure 15). Although the effects may appear subtle, at the point of 
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the largest difference between the absence and presence of nanoparticles, namely in the middle 
of the phase transition, the elasticity is increased by approximately 31%. The range of pressures 
over which the elasticity is increased is greater for Infasurf, in agreement with a broad phase 
transition due to the complexity of the composition of this multicomponent mixture. Given the 
pendant drop cannot reach the pressures high enough for significant reservoir formation, it is not 
clear what impact the nanoparticles will have on this process. 
In all cases the Bindzil DI nanoparticles, which actually carry higher charge density than the 
anionic Bindzil nanoparticles show the same effect but significantly more pronounced, 
highlighting that the charge density plays an important role in determining the extent of impact 
(see Appendix A). 
 
Figure 15. Viscoelasticity measurements of Infasurf monolayers spread on different 
subphases at room temperature: water (black), 0.001 wt% cationic silica nanoparticles 
(red) and 0.001 wt% anionic silica nanoparticles (blue). Each data set comprises duplicate 
measurements made on two, independently prepared films. 
3.2.3. Structural analysis of model membranes spread on silica 
nanoparticle subphases 
As mentioned earlier, GIXD diffraction peaks are only observed when there is an ordered surface 
phase present. A surface pressure of 35 mN/m was chosen to ensure all systems had phase 
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separated but that squeeze-out and reservoir formation had not yet taken place. GIXD was used 
to assess the impact of the nanoparticles on the lateral lipid structure within the condensed phase. 
Figure 16 shows the GIXD images of the DPPC monolayer in the presence and absence of 0.001 
wt% cationic and anionic nanoparticles. The presence of out-of-plane peaks (i.e. peaks with a 
center at Qz>0) indicate that there is a tilt in the lipid chains. The sharpness of the peaks is an 
indication of the crystallinity of the condensed phase: the sharper the peaks the more crystalline 
or ordered the surface phase. In agreement with the literature, DPPC exhibits three peaks, all at 
Qz>0, indicative of an oblique lattice with an intermediate tilt, i.e. between Nearest Neighbour 
(NN) and Next Nearest Neighbour (NNN)99. The calculated tilt angle of the lipid chains (27.1°) 
is also in agreement to that reported in literature99. For all three types of subphases, no change is 
observed for the unit cell since the tilt of the alkyl chains are between that of NN and NNN 
(Table 1). The presence of nanoparticles induces a slight increase in alkyl chain tilt angles (Table 
1), which may be caused by lipid headgroup reorientation due to the presence and interaction 
with the charged nanoparticles100,101. 
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Figure 16. GIXD intensity as a function of the in-plane (Qxy) and out-of-plane (Qz) 
components of the scattering vector for a DPPC monolayer at 35 mN/m in water (A) 0.001 
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Table 1. Summary of lattice type, tilt azimuth and tilt angles measured by GIXD for DPPC 
monolayers. 
System π (mN/m) Lattice Tilt Azimuth Tilt Angle (°) 
DPPC 
Water 35 Oblique Intermediate 27.1 
Cationic 35 Oblique Intermediate 31.3 
Anionic 35 Oblique Intermediate 32.7 
 
Figure 17 shows the GIXD images of the 70:30 DPPC:DLPC monolayer in the presence and 
absence of 0.001 wt% cationic and anionic nanoparticles. Once again, the presence of out-of-
plane peaks are indicative of lipid chain tilt. DPPC and DLPC share the same headgroup but 
differ in lipid chain lengths. Due to the shorter lipid chains, a pure DLPC monolayer is unable to 
reach C phase and stays in the LE phase till film collapse. However, this monolayer has been 
reported to show phase separation with partial miscibility102. Therefore, it is possible that mixing 
DPPC with DLPC (70:30 ratio) causes the resulting monolayer to have a reduced amount of 
condensed phase and as a result the diffraction peaks have significantly lower intensity and a 
higher background noise is observed (Figure 17) compared to the DPPC monolayers (Figure 16). 
The alkyl chain tilt angle in water subphase for the mixed monolayer (28.4°) is larger than that of 
DPPC in water subphase (27.1°) which is most likely due to the presence of the short chain 
DLPC incorporated into the DPPC condensed phase. Similarly to DPPC monolayer, the 70:30 
DPPC:DLPC monolayer also has an oblique unit cell in all three types of subphase with very 
little change in alkyl chain tilt, where the changes can be attributed to lipid headgroup 
reorientation due to their interaction with the charged nanoparticles. Unlike the DPPC 
monolayer, in the presence of anionic nanoparticles for the mixture there is a decrease in tilt 
angle and this may be due to the DLPC being incorporated in the condensed phase monolayer 
(Table 2). 
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Figure 17. GIXD intensity as a function of the in-plane (Qxy) and out-of-plane (Qz) 
components of the scattering vector for a 70:30 DPPC:DLPC monolayer at 35 mN/m in 
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Table 2. Summary of lattice type, tilt azimuth and tilt angles measured by GIXD for 70:30 
DPPC:DLPC monolayers. 
System π (mN/m) Lattice Tilt Azimuth Tilt Angle (°) 
70:30 
DPPC:DLPC 
Water 35 Oblique Intermediate 28.4 
Cationic 35 Oblique Intermediate 28.4 
Anionic 35 Oblique Intermediate 26.7 
 
Figure 18 shows the GIXD images of 70:30 DPPC:POPG monolayer in the presence and absence 
of 0.001 wt% cationic and anionic nanoparticles. Contrary to GIXD images for the 70:30 
DPPC:DLPC monolayer (Figure 17) there is significantly less background noise for the 70:30 
DPPC:POPG monolayer (Figure 18) indicating that the intensity of diffraction is higher since 
there is more condensed phase present in the monolayer. The three diffraction peaks (Figure 18) 
and an oblique unit cell (Table 3) observed are in agreement with the literature for this 
monolayer, however the lipid tilt angle is decreased (Table 3)68. Bringezu et al. have reported 
that POPG can partially incorporate into the DPPC condensed phase and since the size of POPG 
headgroup is smaller than that of DPPC this mixed condensed phase has a tighter packing of 
headgroups which results in a lower tilt angle68. Similar to the two previous systems, DPPC and 
70:30 DPPC:DLPC, an oblique unit cell is observed for water and anionic nanoparticle subphase 
with little change in the lipid chain tilt angle. Unlike the previous two lipid systems, the presence 
of cationic nanoparticles induces a significant change in the unit cell and lipid chain tilt angle. 
The calculated tilt angle for the lipid chains in the presence of cationic nanoparticles is 6.8° and 
the unit cell is centered rectangular (Table 3), such low tilt angles have been observed in the 
presence of chaotropic agents  that disturb the hydrogen bonding network 103. Since such a 
drastic change in tilt angle was not observed with DPPC monolayer in the presence of cationic 
nanoparticles, the change can be attributed to the presence of anionic POPG present in the DPPC 
condensed phase domains, which interacts strongly with the cationic nanoparticles. 
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Figure 18. GIXD intensity as a function of the in-plane (Qxy) and out-of-plane (Qz) 
components of the scattering vector for a 70:30 DPPC:POPG monolayer at 35 mN/m in 
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Table 3. Summary of lattice type, tilt azimuth and tilt angles measured by GIXD for 70:30 
DPPC:POPG monolayers. 
System π (mN/m) Lattice Tilt Azimuth Tilt Angle (°) 
70:30 
DPPC:POPG 





Anionic 35 Oblique Intermediate 22.7 
 
GIXD data was also obtained for Infasurf monolayers (Appendix B) but the complex lipid 
composition yields multiple phases such that a definitive fit could not be obtained.  Qualitatively, 
the effects are similar to those observed with DPPC:POPG, namely a slight expansion of the unit 
cell in the presence of anionic nanoparticles and a reduction in title angle in the presence of 
cationic nanoparticles. 
3.3. Concentration studies on model membranes 
In section 3.2 it was shown that low concentrations of nanoparticles can impact the 
physicochemical properties of the model lung surfactant films. In order to determine the impact 
of nanoparticle concentration, studies were performed with the two model systems that best 
represented the lung surfactant, 70:30 DPPC:POPG (lipid-only system with the charged LE 
phase) and Infasurf (lipid-protein system), with concentrations ranging from 0.001 wt% to 0.5 
wt%. In order to ensure equilibration at each concentration of dispersed nanoparticles in the 
subphase, films were all allowed to equilibrate for 30 minutes prior to performing isotherms and 
rheology experiments. In order to control the lipid:nanoparticle ratio (200:1), the same amount of 
lipid was always spread on the surface of a 40 mm2 drop and the NP concentration was varied. 
As a result, if the nanoparticle induces a film expansion, the shift can be sufficiently large such 
that a gaseous phase cannot be observed. 
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3.3.1. Impact of cationic nanoparticles as a function of concentration 
The surface pressure-area isotherms for 70:30 DPPC:POPG and Infasurf on water with 
increasing concentrations (given as wt% of subphase) of cationic silica nanoparticles obtained 
with the pendant drop tensiometer are shown in Figure 19. In all of the DPPC:POPG isotherms, 
the LE-C phase transition starting around 10 mN/m is visible. With increasing concentration of 
cationic nanoparticles in the subphase the isotherm is shifted to higher molecular areas 
suggesting that increasingly more nanoparticles are attracted to the anionic lipid film.  However, 
it must be noted that the shift in molecular area does not scale linearly with nanoparticle 
concentration.  In particular the isotherms for 0.01 wt% and 0.1 wt% Levasil are, within 
experimental error, identical.  Notably there is a distinct shape change in addition to a shift to 
higher molecular areas at 0.5 wt% cationic nanoparticles and a much lower collapse (the film 
pressure begins to plateau and drop at 50 mN/m). These suggest that there may be a point at 
which the film is saturated with adsorbed nanoparticles and begins to exhibit behaviour of a 
nanoparticle film rather that a lipid film. Shifts to higher molecular areas are also observed for 
cationic nanoparticles interacting with Infasurf but the shifts are much smaller, indicating that the 
presence of the cationic protein SP-B reduces the net attraction of the cationic nanoparticles to 
the surface. This is in agreement with previous findings that the SP-B can screen counterions and 
other charged species from the surface96. Despite the smaller shift, again 0.5 wt% has a clear 
impact near the squeeze-out pressure of 50 mN/m and alters this squeeze-out plateau, suggesting 
that such a high concentration of nanoparticles in the subphase alters the squeeze-out process and 
may alter the film buckling process and mechanism. In the absence of surfactant proteins, lipid 
films collapse via a fracture mechanism while in the presence of the surfactant proteins this is 
modified to a folding process52. The cationic nanoparticles may either interfere with the ability of 
the proteins to carry out their function or the particles themselves may facilitate collapse via a 
different mechanism. 
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Figure 19. Surface pressure–area isotherms of 70:30 DPPC:POPG (A) and Infasurf (B) 
monolayers in cationic nanoparticles with increasing particle concentration at room 
temperature. 
The viscosity and elasticity data for the two films in the presence of varying concentrations of 
nanoparticles are shown in Figure 20. The features of the viscosity versus surface pressure and 
elasticity versus surface pressure were describe in the previous chapter. Despite significant shifts 
in the DPPC:POPG isotherms, the viscosity and elasticity of the films remain relatively unaltered 
for all concentrations below 0.5 wt% nanoparticles. Thus, although the area at which the film 
reaches a given pressure is modified by the presence of the particles, the viscoelastic properties 
of the film are determined predominantly by the surface pressure. As noted in the previous 
section, there is a small increase in film elasticity at pressures above 15 mN/m amounting to a 
31% increase over the phase transition region. 
When the particle concentration is further increased to 0.5%, the viscosity and elasticity values 
are altered significantly; the film properties are not simply a function of surface pressure, shifted 
only in molecular area at this pressure and corresponding viscoelastic properties are achieved. 
Rather, the film adopts a new behaviour, likely reflecting the behaviour of a fully saturated 
nanoparticle film. In particular the elasticity is now impacted even at low pressures, reaching 
values, at the peak maximum, four times those of the other films.  The earlier collapse of the film 
is noticeable by the distinct decrease in elasticity starting around 30 mN/m. For both viscosity 
and elasticity the data is significantly more scattered which may also be an indicator that the 
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measurements no longer reflect a lipid film but rather a nanoparticle film.  In this case, the 
amplitude and frequency used for the measurements were optimized for lipid film measurements 
and the scatter may indicate a need for different parameters104. 
Similar effects are seen with Infasurf.  For particle concentrations lower than 0.5 wt%, the 
viscosity and elasticity are determined simply by the surface pressure of the film, even if the area 
at which this pressure occurs is altered.  Again, a high particle concentration of 0.5 wt% can 
induce changes to the viscosity or elasticity of the film at a given surface pressure, but the effects 
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Figure 20. Viscoelasticity measurements of 70:30 DPPC:POPG (A and B) and Infasurf (C 
and D) monolayers in cationic nanoparticles with increasing particle concentration at room 
temperature. 
3.3.2. Impact of anionic nanoparticles as a function of concentration 
The surface pressure–area isotherms of the two monolayer systems in the presence of anionic 
nanoparticles at different concentrations are shown in Figure 21. For the DPPC:POPG isotherms, 
the phase transition is still present, however, with the anionic nanoparticles present in the 
subphase, it is less distinct than it was with cationic nanoparticles. As with the cationic 
nanoparticles there is a non-monotonic increase in molecular area with increasing concentration 
of anionic nanoparticles in the subphase. In principle, the monolayer is negatively charged but it 
is not a homogeneous film and the anionic nanoparticles may interact with the zwitterionic 
DPPC-rich condensed phase. Although the shifts with increasing concentration of anionic 
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nanoparticles exhibit the same non-monotonic trend as observed with cationic nanoparticles, the 
isotherm at the highest anionic nanoparticle concentration of 0.5 wt% does not show the distinct 
change in isotherm shape or reduction in collapse pressure observed with cationic nanoparticles. 
Guzman et al. showed a similar result with 1 wt% anionic silica nanoparticles interaction with 
DPPC:DOPC:Cholesterol, namely a shift to higher surface areas104. For DPPC:POPG there is 
relatively little shape change, indicating that the expansion may be a simple excluded area effect 
while the phosphocholine and cholesterol system exhibits subtle shape changes suggesting an 
additional interaction with the lipid components. The charge repulsion may reduce such effects 
in DPPC:POPG in agreement with the lack of change to the condensed phase structure discussed 
in section 3.2.3104. 
The isotherms for Infasurf in the presence of anionic nanoparticles again show smaller shifts to 
higher molecular areas with similar shape to the isotherm in the absence of nanoparticles or in 
the presence of cationic nanoparticles (Figure 21).  In agreement with the DPPC:POPG results, 
the isotherm of Infasurf on a subphase of 0.5 wt% anionic nanoparticles does not exhibit the 
changes in the squeeze-out plateau observed at high concentrations of cationic nanoparticles. 
 
Figure 21. Surface pressure–area isotherms of 70:30 DPPC:POPG (A) and Infasurf (B) 
monolayers in anionic nanoparticles with increasing particle concentration at room 
temperature. 
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On the other hand, despite the isotherms appearing to exhibit only shifts to higher molecular, the 
viscosity and elasticity of the monolayers are distinctly altered in the presence of anionic 
nanoparticles (Figure 22). For the DPPC:POPG system, an effect on viscosity is seen even with 
the lowest nanoparticle concentration, although impact on elasticity is only observed for 0.01 
wt% and higher nanoparticle concentrations. Specifically,  although the shape of viscosity versus 
surface pressure and elasticity versus surface pressure curves have similar shapes, the increase in 
viscosity and elasticity associated with the loss of the LE phase appears to shift to higher 
molecular areas. Also, the changes associated with the LE-C phase transition are less distinct in 
the presence of nanoparticles. As discussed in section 3.1, at surface pressures of 30 mN/m and 
above, POPG begins to be squeezed-out of the monolayer and the viscosity and elasticity 
increase as the film begins to comprise a greater proportion of DPPC-rich condensed phase. The 
viscosity and elasticity data appear to be more sensitive to the proportion of the two phases than 
the isotherms105.  The loss of the negatively charged LE phase appears delayed (likely due to 
repulsion with the anionic nanoparticles in the subphase), moreover the loss appears to occur 
over a narrower range of surface pressures (sharper transition).  Of course, as the anionic LE 
phase is lost, the attraction of the anionic nanoparticles to the residual zwitterionic DPPC-rich 
condensed phase increases. Additionally, POPG shields the surface from being completely 
saturated with the anionic nanoparticles and therefore the drastic shape change at 0.5% 
nanoparticle concentration was not observed. It should be noticed that with increasing 
nanoparticle concentration it becomes more difficult to replicate data.  
As with DPPC:POPG, Infasurf exhibits distinct changes in viscosity and elasticity in the 
presence of anionic nanoparticles, in contrast to the presence of cationic nanoparticles, despite 
the similarity in isotherms. The viscosity is increased subtly around 30 mN/m but it must also be 
noted that the data is also more scattered.  On the other hand, the elasticity is significantly 
impacted in the presence of anionic nanoparticles. A significant increase in elasticity is observed 
with the lowest anionic nanoparticle concentration and this effect is observed with the higher 
nanoparticle concentration as well. The elasticity starts to increase at 15-20 mN/m (which is the 
end of the phase transition) and elasticity increases by approximately 29% compared to the 
absence of nanoparticles (Figure 22-D). For the 0.001% and 0.01% the elasticity values reach a 
maximum at 25 mN/m and then decreases to return to values similar to those in the absence of 
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nanoparticles. However, for the higher concentrations of nanoparticles (0.1 wt% and 0.5 wt%) 
the decrease in elasticity only begins at higher pressure values (37 mN/m). 
 
Figure 22. Viscoelasticity measurements of 70:30 DPPC:POPG (A and B) and Infasurf (C 
and D) monolayers in anionic nanoparticles with increasing particle concentration at room 
temperature. 
Broicksitter et al. studied the effect of cationic and anionic polymer nanoparticle exposure on 
lung surfactant by co-spreading polylactic acid nanoparticles on Curosurf. They observed that 
upon the addition of nanoparticles there was a decrease in the amount of protein present. Binding 
of proteins to the nanoparticles caused a decrease in lung surfactant activity. This effect was 
more significant with the use of negatively charged nanoparticles rather than positively charged 
nanoparticles since SP-B and SP-C have an overall positive charge. Furthermore, this effect 
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occurred in a dose dependent manner where the surfactant monolayer was observed to have lost 
all surface activity at high concentration of anionic nanoparticles (about 0.1 wt% of 
nanoparticles)106. Similarly, with the charged silica nanoparticles, the impact on viscoelastic 
properties are significantly amplified with anionic nanoparticles compared to cationic 
nanoparticles, i.e. despite similar effects on the surface pressure-area isotherms, the cationic 
nanoparticles do not seem to have any impact on viscosity or elasticity until very high 
concentration of nanoparticles are present, whereas, the anionic nanoparticles impact the 
mechanical properties at even the lowest nanoparticle concentration. As mentioned before, the 
surface active proteins are viscosity and elasticity regulators, however, if they are bound to 
nanoparticles then they will not be able to carry out their functions.  Although it takes a 
significantly larger concentration of cationic nanoparticles to see an effect on viscoelastic 
properties, the effect is observed and it also shows that anionic nanoparticles are indeed more 
potent in decreasing lung surfactant mechanical properties. This was also observed by Sachan 
and Galla who studied the interaction of polyorganosiloxane nanoparticles with model lung 
surfactant monolayer. They concluded that although SP-C protein is present in very small 
amount it plays a crucial role, they help anchor the collapsed unsaturated lipids during 
monolayer compression which can be observed as protrusions below the surface of the 
monolayer, in the presence of nanoparticles there was a decrease in the number and height of 
protrusions. Furthermore, this decrease in number of protrusions was also dose dependent, where 
the effect was more evident with high nanoparticle concentrations (0.1 wt%)107. Ramazani and 
Larson ran molecular simulations to study the effect of nanoparticle hydrophobicity with lipid 
and protein interaction. They have concluded that when the nanoparticle is hydrophobic in nature 
the lipid tail will interact with the nanoparticle surface and the SP-C protein will be interacting 
with the hydrophilic lipid headgroup. However, with decreasing hydrophobicity both lipid and 
protein will be in contact with the nanoparticle surface. When the nanoparticle is hydrophilic in 
nature then the nanoparticle will mainly be in contact with the SP-C protein on its surface and 
the lipids will be in contact with the protein108. 
  
  50 
Chapter 4. Conclusions and future work 
Four different monolayers were studied as models of lung surfactant films in order to gain a 
better understanding of the roles of the different phases and components. Three lipid only films 
and one lipid-protein mixture were studied. The lipid only systems included a single component 
system to represent the condensed phase of lung surfactant and two binary mixtures that 
represent the phase separation in lung surfactant.  For the latter, one comprised a zwitterionic 
liquid expanded phase and the other an anionic liquid expanded phase. The lipid protein mixture, 
that comprised a natural extract of bovine lung surfactant, is significantly more complex in 
composition which can hinder interpretation. The similarity in impact of nanoparticles on 
Infasurf and DPPC:POPG films demonstrate that the charged liquid expanded phase is a 
necessary component in order to better mimic the natural system. This is an important finding 
given that DPPC or phosphocholine mixtures are frequently used to represent lung 
surfactant52,69,90,109. 
We find that anionic silica nanoparticles have a greater impact on film mechanical properties but 
only at high pressures when charge repulsion of the particles and the charged LE phase becomes 
important.  Guzman et al. also found that the impact of anionic silica was greatest at high surface 
pressures and led to a weakening of the monolayer cohesive forces104. Despite these mechanical 
property changes, the anionic particles had relatively little impact on condensed phase structure. 
On the other hand, cationic nanoparticles impact the structure of the condensed phase islands but 
not the rheology.  There is relatively little literature to date on the impact of hydrophilic cationic 
nanoparticles. Taken together these results suggest that the LE-C balance is more important in 
determining viscosity and elasticity than the structure within the condensed phase islands, 
however the structure may have other relevance for stability of the phase at high pressure for 
example.  Moreover, it appears that the anionic nanoparticles impact the macroscale properties of 
the films while the cationic particles impact more the molecular scale properties. 
To better understand the biophysical consequences of the isotherm and rheological changes, the 
impact on effective surface pressure and rheology for the same molecular area range must be 
compared. As an example, in the absence of nanoparticles the DPPC:POPG film can cycle 
between a molecular area of 80-40 Å2/molecule which corresponds to a surface pressure range of 
0-60 mN/m. However, in the presence of 0.5% nanoparticles at an area of 80 Å2/ molecule the 
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lipid film is already at 10 mN/m, which corresponds to the LE-C phase transition, and it 
collapses at 50 mN/m before it can even reach 40 Å2/molecule (refer to Figure 20-B). This would 
mean in the presence of nanoparticles the lung surfactant will be unable to reach the very high 
surface pressure values that it can normally reach and will collapse at a lower surface pressure. 
The lung has a fixed area range and this will alter minimum the maximum surface pressures the 
lung can reach during the breathing cycle and cause a premature film collapse. 
While much of the literature has focused on relatively high nanoparticle concentrations (1 wt%), 
we have shown that structural and rheological changes can be observed at concentrations as low 
as 0.001 wt%, i.e. 1000 times lower than previously reported. Moreover, at the higher 
concentrations, the membrane properties take on characteristics of a particle-laden film which 
may not be realistic for airborne pollutants. This work highlights the potential detrimental impact 
of airborne nanoparticles on lung surfactant functioning at low concentrations. 
One drawback of the methodology is that it uses adsorption from the subphase as the mechanism 
of particle-film interactions.  In order to make the deposition more realistic, future studies should 
focus on introducing the nanoparticles from the air-side to better mimic nanoparticle inhalation. 
For these studies, the frequency of oscillation was optimized for the lipid films. It was held 
constant throughout the experiments in order to make comparisons since the absolute values of 
elasticity and viscosity vary with the frequency and amplitude83. However, as the amount of 
nanoparticles at the interface increases, the optimal frequency for measurement may need to be 
modified. This plays a particularly important role at high nanoparticle concentrations. 
Finally, while the DPPC:POPG presented the best mimetic of Infasurf, it is still only a binary 
mixture and lacks certain relevant components.  Specifically, Infasurf is known to contain 
cholesterol which can induce a liquid-ordered phase and is a known membrane fluidity buffer73.  
A ternary system comprising DPPC:POPG:Cholesterol would provide a useful intermediate for 
understanding the behavior of Infasurf and may be a better simplified lipid only model.  
Additionally, SP-B and SP-C can be purified4,56,72 and these could be systematically added to the 
lipid systems to better understand the role of the proteins. 
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Appendix 
Appendix A: Isotherms and Rheology Data for Bindzil DI (Neutral Particles) 
 
Isotherms of each of the model membrane systems (A: DPPC, B: DPPC:DLPC, C: DPPC:POPG 
and D: Infasurf) on the four subphases (water: black, 0.001 wt% cationic silica nanoparticles: 
red, 0.001 wt% anionic silica nanoparticles: blue and 0.001 wt% neutral silica nanoparticles: 
green). 
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Viscoelasticity measurements of DPPC monolayers spread on different subphases at room 
temperature: water (black), 0.001 wt% cationic silica nanoparticles (red), 0.001 wt% anionic 
silica nanoparticles (blue) and 0.001 wt% neutral silica nanoparticles (green). Each data set 
comprises duplicate measurements made on two, independently prepared films. 
 
Viscoelasticity measurements of 70:30 DPPC:DLPC monolayers spread on different subphases 
at room temperature: water (black), 0.001 wt% cationic silica nanoparticles (red), 0.001 wt% 
anionic silica nanoparticles (blue) and 0.001 wt% neutral silica nanoparticles (green). Each data 
set comprises duplicate measurements made on two, independently prepared films. 
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Viscoelasticity measurements of 70:30 DPPC:POPG monolayers spread on different subphases 
at room temperature: water (black), 0.001 wt% cationic silica nanoparticles (red), 0.001 wt% 
anionic silica nanoparticles (blue) and 0.001 wt% neutral silica nanoparticles (green). Each data 
set comprises duplicate measurements made on two, independently prepared films. 
 
Viscoelasticity measurements of Infasurf monolayers spread on different subphases at room 
temperature: water (black), 0.001 wt% cationic silica nanoparticles (red), 0.001 wt% anionic 
silica nanoparticles (blue) and 0.001 wt% neutral silica nanoparticles (green). Each data set 
comprises duplicate measurements made on two, independently prepared films. 
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Appendix B: GIXD Data for Infasurf monolayers 
 
GIXD intensity as a function of the in-plane (Qxy) and out-of-plane (Qz) components of the 
scattering vector for an Infasurf monolayer at 35 mN/m in water (A) 0.001 wt% cationic 
nanoparticles (B) and 0.001% anionic nanoparticles (C). 
